Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma

BACKGROUND: Antibiotic exposure has been associated with worse outcomes with immune checkpoint inhibitors (ICIs) in cancer patients, likely due to disruption of the gut microbiome. Other commonly prescribed medications, such as proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H2RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Tomi, Ozbek, Umut, Dharmapuri, Sirish, Hardy-Abeloos, Camille, Zhu, Huili, Lin, Jung-Yi, Personeni, Nicola, Pressiani, Tiziana, Nishida, Naoshi, Lee, Pei-Chang, Lee, Chieh-Ju, Hildebrand, Hannah, Nimkar, Neil, Paul, Sonal, Fessas, Petros, Naeem, Muntaha, Bettinger, Dominik, Khan, Uqba, Saeed, Anwaar, Huang, Yi-Hsiang, Kudo, Masatoshi, Rimassa, Lorenza, Marron, Thomas U., Pinato, David J., Ang, Celina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107671/
https://www.ncbi.nlm.nih.gov/pubmed/33995594
http://dx.doi.org/10.1177/17588359211010937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107671/
https://www.ncbi.nlm.nih.gov/pubmed/33995594
http://dx.doi.org/10.1177/17588359211010937

Ejemplares similares